NCT05244330View on ClinicalTrials.gov

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

January 15, 2022

Study Completion Date

January 15, 2022

Conditions
SARS CoV 2 Infection
Interventions
OTHER

Trial Locations (1)

710061

First Affiliated Hospital of Xian JiaotongUniversity, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT05244330 - Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) | Biotech Hunter | Biotech Hunter